Clinical Trial Update: Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma

View source ↗

Summary

This clinical trial from Tianjin Medical University Second Hospital aims to use liquid biopsy testing to identify, monitor, and predict recurrence in urothelial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Snippet

Sponsor: Tianjin Medical University Second Hospital | Conditions: Urothelial Carcinoma (UC), Bladder (Urothelial, Transitional Cell) Cancer | Status: RECRUITING